SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a...
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented positive pre-clinical data...
LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”)...
Patents affirm the continued innovation and commitment to improving quality of life for individuals with low vision and legal blindnessTORONTO,...
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...
ATLANTA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The Georgia Health Information Network (GaHIN), Georgia’s state-designated health information exchange (HIE), has...
First-Of-Its-Kind Lab Test Helps Guide Targeted Treatment Decisions in Rheumatoid ArthritisWALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine,...
HMS’ proven success with workers’ compensation claim recovery efforts has resulted in more than $31 million in recoveries since 2015IRVING,...
VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
ROCKAWAY, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management...
Interview provides insights and excitement surrounding MITI’s new clinic subsidiary “The Good Clinic (TM)” and the opening of its flagship...
Corrie MacColl to produce Vytex from world’s largest rubber plantationWorcester, MA and Norfolk, VA, Feb. 03, 2021 (GLOBE NEWSWIRE) --...
DUBLIN, Ireland and TREVOSE, Pa., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical...
Phase II (16 patients treated, 9/16 (56%) with severe illness, 7/16 (44%) with critical illness, follow-up period of 28 days...
Provides update on U.S. OTC ListingDENVER, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE:...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 03, 2021...
Board Changes Oxford, UK – 3 February, 2021: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading...
Phase 1 study is designed to provide clinical proof-of-concept by taking advantage of established methods in endocrinologySAN DIEGO, Feb. 03,...
Outsourcing vs Inhouse Resourcing For Lateral Flow Test Manufacturing New guide published by leading rapid test developer and manufacturer advises...
- First potentially disease-modifying gene therapy for GM2 gangliosidosis to enter clinical studies- Expect to continue patient identification, screening, and...